IP Library Granted Patent US 8,317,099
Granted Patent B2
US 8,317,099 · App. 11/618,298 · Granted Nov 27, 2012

Systems and methods for managing information relating to medical fluids and containers therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,317,099
App. No.
11/618,298
Granted
Nov 27, 2012
Kind
B2
Abstract

The present invention relates to management of information relating to medical fluids, containers therefore, and medical fluid administration devices for administering such medical fluids to patients. Data tags (e.g., RFID tags) are generally associated with containers of the invention and may be electromagnetically read from and/or written to using an electromagnetic device, for example, that may be associated with a medical fluid administration device of the invention.

Claims (51)

1. A medical fluid injection system, comprising:

a container having contrast media contained therein and an RF data tag attached thereto;

a powerhead having the container coupled thereto and operable to control delivery of the contrast media from the container, the powerhead comprising:

a housing;

a motor within the housing;

a control circuit within the housing to control the motor;

an electromagnetic device operable to read data from the RF data tag; and

a user interface within the housing and accessible to an operator of the powerhead, the user interface including a display operable to display data,

wherein the control circuit includes software instructions which cause the control circuit to read data from the RF data tag by the electromagnetic device and display the data read from the RF data tag combined with changable data from another source.

2. The system of claim 1 , wherein the display is operable to display data indicative of a presence of at least one of the container and the RF data tag on the container.

3. The system of claim 1 , wherein the display is operable to display the data in response to user interaction with the display.

4. The system of claim 1 , wherein the electromagnetic device is operable to write data to the RF data tag.

5. The system of claim 1 , wherein the display is operable to display the data read from the RF data tag overlaying other data displayed on the display.

6. The system of claim 1 wherein the display is configured to display data indicative of

an amount of the contrast media in the container.

7. The system of claim 1 , wherein the display is operable to provide an active user interface.

8. A method of operation for a medical fluid injection system, the method comprising:

coupling a container having contrast media therein with a powerhead of a medical fluid injection system, the powerhead comprising a housing, a motor, a control circuit within the housing to control the motor, and a user interface within the housing that is accessible to an operator of the powerhead, wherein the user interface comprises a display;

reading data from an RF data tag of the container while the container is coupled with the powerhead; and

displaying at least some of the data read from the RF data tag on the display of the user interface of the powerhead combined with changeable data from another source.

9. The method of claim 8 , further comprising:

displaying a representation of the container;

interrogating the container for the RF data tag; and

in response to finding the RF data tag, indicating a presence of the RF data tag on the representation of the container on the display.

10. The method of claim 8 , further comprising:

writing data to the RF data tag while the container is coupled with the powerhead.

11. The method of claim 8 , wherein the data read from the RF data tag is displayed overlaying other data displayed on the display.

12. The method of claim 8 , wherein the displaying comprises displaying data indicative of at least one of

an amount of the contrast media in the container,

an identity of the contrast media in the container,

manufacturing information for the contrast media in the container,

a radioactivity level of a contrast media in the container,

a use code for the contrast media in the container,

configuration information for the injection system,

whether or not the container was previously used with this or another injection system,

a lot number of the contrast media in the container, and

an expiration date of the contrast media in the container.

13. The system of claim 1 , wherein the user interface includes a touch screen.

14. The method of claim 8 , wherein the user interface includes a touch screen.

15. The method of claim 14 , further comprising:

accessing the data from the RFID data tag by way of manipulating the touch screen.

16. The system of claim 1 , wherein the container comprises a syringe.

17. The method of claim 8 , wherein the container comprises a syringe.

18. The system of claim 1 wherein the display is configured to display data indicative of an identity of the contrast media in the container.

19. The system of claim 1 wherein the display is configured to display data indicative of manufacturing information for the contrast media in the container.

20. The system of claim 1 wherein the display is configured to display data indicative of a radioactivity level of a contrast media in the container.

21. The system of claim 1 wherein the display is configured to display data indicative of a use code for the contrast media in the container.

22. The system of claim 1 wherein the display is configured to display data indicative of configuration information for the injection system.

23. The system of claim 1 wherein the display is configured to display data indicative of whether or not the container was previously used with this or another injection system.

24. The system of claim 1 wherein the display is configured to display data indicative of a lot number of the contrast media in the container.

25. The system of claim 1 wherein the display is configured to display data indicative of an expiration date of the contrast media in the container.

Assignments (4)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →